Bionano Genomics Inc (BNGO)
$0.76
0.00 (0.00%)
BNGO Stock Quote Delayed 30 Minutes
Bionano Genomics (BNGO) Stock Pops on Promising Publication
BNGO stock is on the move as just-released research study results offer hope in the ongoing battle against cancer.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 ā FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report ā FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out ā FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why ā FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
211.87M
PE Ratio
-0.14
EPS
-5.54
Volume (Avg. Vol.)
5,739
Day's Range
-
52-Week Range
$0.71 - $8.20
Dividend & Yield
N/A (N/A)
BNGO Stock Predictions, Articles, and Bionano Genomics Inc News
What Is Going on With Bionano Genomics (BNGO) Stock Today?
Bionano Genomics (BNGO) stock is rising higher on Wednesday after providing an update on its Long String VANTAGE product.
Why Is Bionano Genomics (BNGO) Stock Up 11% Today?
Bionano Genomics (BNGO) stock is rising higher on Wednesday following the publication of a study related to optical genome mapping (OGM).
Todayās Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another overview of the biggest pre-market stock movers for Wednesday as we cover the news behind share movement this morning!
Why Is Bionano Genomics (BNGO) Stock Up 20% Today?
Bionano Genomics is in the news again, delivering groundbreaking nanoscale analytics research that has BNGO stock reaching for the stars.
Bionano Genomic (BNGO) Stock Pops on Research Study
Bionano Genomic is in the news today as a landmark research focusing on genomic mapping technology bolsters BNGO stock.
The Latest Studies by Bionano Genomics Are Promising, But It’s Not a Buy Yet
BNGO stock has provided positive news from study results lately, but its fundamentals are not great and not a reason to invest in it now.
Why Bionano Genomics Stock Is Risky, but a Good Bet
The risks may be clear when it comes to Bionano Genomics and BNGO stock. However, investors should see this as a long-term play.
Bionano Genomics Stock Can Regain the Crucial $5 Level
Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon.
Bionano Genomics May Finally Offer a Reward for Your Risk
BNGO stock has been a falling knife for the past year. But, with promising fundamentals and good tailwinds, now be the time to take a chance.
Hold On to Bionano Genomics Stock Until It Reaches $6 at Least
One analyst is modeling significant upside for BNGO stock, and there's financial data to suggest that a 3x move is entirely possible.
Bionano Genomics Has Attractive Applications But An Unattractive Stock Price
Bionano GenomicsĀ (NASDAQ:BNGO) is a life sciences instrumentation company focused on the genome analysis space. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano…
Bionano Stock Looks to Have a Monster Comeback in Its Future
Bionano's Saphyr appears to be able to help doctors treat leukemia more effectively, and adoption of its device is growing rapidly. BNGO stock is a buy.
Investors Have Cast Their ‘No’ Votes Against Bionano Genomics
A preliminary report from Bionano Genomics doesn't tell the full story and a lack of profitability will likely weigh on BNGO stock.
